Alzheimer's Disease

What Is Alzheimer’s Disease? Understanding Symptoms, Causes, Diagnosis, and Treatment

Alzheimer’s Disease (AD) is the most common cause of dementia in older adults, accounting for 60–80% of all dementia cases. It is a progressive neurodegenerative disorder that leads to a gradual decline in memory, thinking, behavior, and the ability to perform everyday activities.

Key Characteristics and Symptoms

Alzheimer’s typically begins with mild memory loss, especially short-term memory, and progressively impairs:

• Cognitive abilities (e.g., decision-making, reasoning)

• Executive functions (e.g., planning, problem-solving)

• Language and communication

• Visuospatial skills (e.g., recognizing objects or navigating spaces)

As the disease advances, patients often experience personality and behavioral changes, including depression, apathy, social withdrawal, agitation, and confusion. In its severe stages, Alzheimer's leads to complete dependency and loss of independent function.

Causes and Risk Factors

The exact cause of Alzheimer’s disease remains unclear. However, it is believed to result from a complex interaction of:

• Genetic predisposition (such as the APOE ε4 allele)

• Environmental exposures

• Lifestyle factors (e.g., diet, physical activity, cardiovascular health)

Brain Changes and Pathophysiology

Alzheimer’s is biologically defined by two hallmark abnormalities in the brain:

1. Amyloid-beta plaques – clumps of protein that accumulate between neurons and disrupt cell function.

2. Neurofibrillary tangles of tau protein – twisted fibers that build up inside brain cells and interfere with transport mechanisms.

These changes lead to synaptic loss, neuroinflammation, oxidative stress, and widespread neuronal death, particularly in regions responsible for memory and cognition, such as the hippocampus and cortex.

Diagnosis of Alzheimer’s Disease

Diagnosis involves a comprehensive clinical evaluation, including:

• Medical history and cognitive testing

• Neuroimaging (e.g., MRI or PET scans to detect brain atrophy and amyloid buildup)

• Cerebrospinal fluid (CSF) analysis for biomarkers like amyloid-beta and tau

Emerging blood-based biomarkers are also being explored for early detection.

Treatment and Management

There is currently no cure for Alzheimer’s disease. However, available treatments aim to slow symptom progression and enhance quality of life:

• Medications:

  • Cholinesterase inhibitors (e.g., donepezil, rivastigmine)

  • NMDA receptor antagonists (e.g., memantine)

• Supportive therapies:

  • Cognitive rehabilitation

  • Behavioral therapy

  • Caregiver support and education

  • Environmental modifications

New disease-modifying therapies targeting amyloid and tau pathology are under active investigation and may soon shift the treatment landscape.

Prevention and Risk Reduction

A growing body of research supports the role of preventive strategies in reducing Alzheimer’s risk, including:

• Regular physical activity

• Mediterranean-style diet

• Cognitive engagement and lifelong learning

• Social connection

• Cardiovascular health management (e.g., controlling hypertension, diabetes, cholesterol)

Ongoing Research and Hope for the Future

Scientific advancements are shedding light on the genetic, molecular, and immune mechanisms driving Alzheimer’s disease. Novel biomarkers and neuroimaging tools are enabling earlier detection, while clinical trials continue to evaluate targeted treatments.

Additionally, emerging evidence suggests a link between chronic gut inflammation and Alzheimer’s disease, pointing to the potential role of the gut-brain axis in disease progression.

Further Reading and References:

• National Institute on Aging – Alzheimer’s Disease Fact Sheet

• Mayo Clinic – Alzheimer's Disease Overview

• Alzheimer’s Association – What Is Alzheimer’s?

• CDC – Reducing Risk of Alzheimer’s Disease

• Alzheimer’s Society UK – Alzheimer’s Disease

• Alzheimers.gov

• Reference Study: Heston MB, Hanslik KL, Zarbock KR, et al. Gut inflammation associated with age and Alzheimer’s disease pathology: a human cohort study. Sci Rep. 2023;13:18924. DOI: 10.1038/s41598-023-45929-z